Meloxicam Tetrafarma (Meloxicam)

Meloxicam works by selectively inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which reduces the production of prostaglandins—chemical mediators that cause inflammation, pain, and fever. By lowering prostaglandin levels, meloxicam diminishes the inflammatory response while sparing COX‑1 activity that protects the stomach lining.

The appropriate dose of Meloxicam Tetrafarma is determined by the prescribing clinician based on the patient’s condition, severity, and overall health. Dosage adjustments may be needed for renal or hepatic impairment, and the prescriber will provide specific instructions.

Meloxicam is generally not recommended during pregnancy, especially in the third trimester, because of potential risks to the fetus. It should also be used with caution while breastfeeding, as it may pass into breast milk. The prescriber will weigh benefits against risks for each individual.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Meloxicam offers a more selective COX‑2 inhibition compared with non‑selective NSAIDs such as ibuprofen or naproxen, which may result in a lower incidence of gastrointestinal side effects. However, cardiovascular and renal risks remain, and the choice of NSAID should be individualized based on patient risk factors.

Meloxicam Tetrafarma should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain its stability and potency.

Meloxicam Tetrafarma is taken orally, usually with or without food as directed by the prescriber. Swallow the tablet whole with a full glass of water; do not crush or chew unless specifically instructed.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, severe skin reactions, liver injury, and acute kidney damage. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Meloxicam should be avoided in patients with known hypersensitivity to meloxicam or other NSAIDs, active gastrointestinal ulceration, severe heart failure, or uncontrolled hypertension. It is also contraindicated in the third trimester of pregnancy and in individuals with significant renal or hepatic impairment unless the prescriber decides otherwise.